Pecavaptan
N/A
Report date: 2026/05/21 20:00:22
NME
Base Information
Drug NamePecavaptan
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[11]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBayer AG
China Registration ClassN/A
Develop Information
Active CompaniesBayer Healthcare Company Ltd
Inactive CompaniesBayer AG
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A